Oncternal Therapeutics, Inc. focuses on the development of oncology therapies for cancers with critical unmet medical needs. Company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1)
Market Cap | 25.416 Million | Shares Outstanding | 58.969 Million | Avg 30-day Volume | 160.623 Thousand |
P/E Ratio | 0.0 | Dividend Yield | 0.0 | EPS | -0.21 |
Price to Revenue | 26.8425 | Debt to Equity | 0.0 | EBITDA | -45.334 Million |
Price to Book Value | 0.4781 | Operating Margin | -6675.720800000001 | Enterprise Value | -22.616 Million |
Current Ratio | 8.248 | EPS Growth | 0.111 | Quick Ratio | 7.823 |
1 Yr BETA | 1.0445 | 52-week High/Low | 1.33 / 0.26 | Profit Margin | -6330.0455 |
Operating Cash Flow Growth | -1.2501 | Free Cash Flow to Firm (FCFF) TTM | -29.57 Million | Free Cash Flow to Equity (FCFE) TTM | -30.795 Million |
Altman Z-Score | -6.7095 |
Please sign in first
none
none
none
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
BREITMEYER JAMES B CHIEF EXECUTIVE OFFICER |
|
0 | 2023-10-02 | 5 |
VINCENT RICHARD G CHIEF FINANCIAL OFFICER |
|
0 | 2023-10-02 | 5 |
LEAVITT CHASE C. GENERAL COUNSEL/SECRETARY |
|
0 | 2023-10-02 | 5 |
YAZJI SALIM CHIEF MEDICAL OFFICER |
|
0 | 2023-10-02 | 5 |
KRISHNAN RAJESH CHIEF TECHNICAL OFFICER |
|
0 | 2023-10-02 | 4 |
|
0 | 2023-06-28 | 1 | |
|
0 | 2023-06-28 | 1 | |
|
0 | 2023-06-28 | 1 | |
|
0 | 2023-06-28 | 1 | |
|
0 | 2023-06-28 | 1 | |
|
0 | 2023-06-28 | 1 | |
|
0 | 2023-06-28 | 1 | |
|
0 | 2023-06-28 | 1 | |
|
0 | 2023-06-28 | 3 | |
KAUFMANN GUNNAR F. CHIEF SCIENTIFIC OFFICER |
|
94,726 | 2023-06-12 | 3 |
|
25,000 | 2022-06-16 | 0 | |
BILINSKY IGOR CHIEF BUSINESS OFFICER |
|
0 | 2021-02-11 | 0 |
AKER HAZEL M LEGAL COUNSEL |
|
51,271 | 2020-07-21 | 0 |
|
3,544,431 | 2020-07-21 | 0 | |
|
1,049,317 | 2020-07-21 | 0 | |
|
0 | 2020-06-11 | 0 | |
HSU FRANK J. CHIEF MEDICAL OFFICER |
|
0 | 2020-03-17 | 0 |
|
0 | 2019-09-12 | 0 | |
|
0 | 2019-06-07 | 0 | |
|
6,877,615 | 2019-01-02 | 0 | |
|
36,759 | 2019-01-02 | 0 | |
|
44,105 | 2018-10-01 | 0 | |
YOUNG DIANE C. VP, CHIEF MEDICAL OFFICER |
|
45,936 | 2018-07-13 | 0 |
DOGGRELL HENRY PATTON VP, CHIEF LEGAL OFFICER |
|
48,175 | 2018-06-20 | 0 |
SHACKELFORD JASON T PRIN FIN. & ACCT. OFFICER |
|
19,548 | 2018-06-20 | 0 |
|
0 | 2018-05-10 | 0 | |
HANOVER MARC STEVEN CHIEF EXECUTIVE OFFICER |
|
172,049 | 2018-01-05 | 0 |
|
4,729,417 | 2017-09-29 | 0 | |
|
48,469 | 2015-01-02 | 0 | |
DALTON JAMES T VP, CHIEF SCIENTIFIC OFFICER |
|
0 | 2014-06-06 | 0 |
|
6,165,261 | 2014-03-19 | 0 | |
STEINER MITCHELL SHUSTER CHIEF EXECUTIVE OFFICER |
|
4,673,367 | 2014-01-29 | 0 |
MOSTELLER MARK EDWARD VICE PRESIDENT, CFO |
|
7,282 | 2013-07-08 | 0 |
|
195,668 | 2013-01-01 | 0 | |
MORTON RONALD A JR VP, CHIEF MEDICAL OFFICER |
|
0 | 2012-01-01 | 0 |
|
157,339 | 2011-07-01 | 0 | |
DEENER GREGORY A VICE PRESIDENT |
|
0 | 2011-01-01 | 0 |
|
0 | 2010-04-30 | 0 | |
BARNETTE K GARY VICE PRESIDENT |
|
No longer subject to file | 2008-07-30 | 0 |
HESSELBERG JEFFREY G VICE PRESIDENT, REGULATORY |
|
No longer subject to file | 2008-07-30 | 0 |
WEST CHRISTOPHER K VICE PRESIDENT - SALES |
|
No longer subject to file | 2008-07-30 | 0 |
BROWN MICHAEL DENNY VICE PRESIDENT |
|
No longer subject to file | 2008-07-30 | 0 |
DODSON SHONTELLE VICE PRESIDENT |
|
No longer subject to file | 2008-07-30 | 0 |
RODRIGUEZ DOMINGO VICE PRESIDENT |
|
No longer subject to file | 2008-07-30 | 0 |
CLARKSON ANDREW M |
|
No longer subject to file | 2008-06-30 | 0 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No current insider transactions |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|---|---|---|---|
ONCTERNAL THERAPEUTICS INC ONCT | 2023-12-08 22:15:04 UTC | -2.776 | 8.096 | 1600000 |
ONCTERNAL THERAPEUTICS INC ONCT | 2023-12-08 21:45:04 UTC | -2.776 | 8.096 | 1600000 |
ONCTERNAL THERAPEUTICS INC ONCT | 2023-12-08 21:15:04 UTC | -2.776 | 8.096 | 1600000 |
ONCTERNAL THERAPEUTICS INC ONCT | 2023-12-08 20:45:04 UTC | -2.776 | 8.096 | 1600000 |
ONCTERNAL THERAPEUTICS INC ONCT | 2023-12-08 20:15:07 UTC | -2.776 | 8.096 | 1600000 |
ONCTERNAL THERAPEUTICS INC ONCT | 2023-12-08 19:45:04 UTC | -2.776 | 8.096 | 1600000 |
ONCTERNAL THERAPEUTICS INC ONCT | 2023-12-08 19:15:03 UTC | -2.776 | 8.096 | 1600000 |
ONCTERNAL THERAPEUTICS INC ONCT | 2023-12-08 18:45:03 UTC | -2.776 | 8.096 | 1600000 |
ONCTERNAL THERAPEUTICS INC ONCT | 2023-12-08 18:15:04 UTC | -2.776 | 8.096 | 1600000 |
ONCTERNAL THERAPEUTICS INC ONCT | 2023-12-08 17:45:03 UTC | -2.776 | 8.096 | 1600000 |
ONCTERNAL THERAPEUTICS INC ONCT | 2023-12-08 17:15:03 UTC | -2.776 | 8.096 | 1600000 |
ONCTERNAL THERAPEUTICS INC ONCT | 2023-12-08 16:45:05 UTC | -2.776 | 8.096 | 1600000 |
ONCTERNAL THERAPEUTICS INC ONCT | 2023-12-08 16:15:04 UTC | -2.776 | 8.096 | 1600000 |
ONCTERNAL THERAPEUTICS INC ONCT | 2023-12-08 15:45:04 UTC | -2.776 | 8.096 | 1600000 |
ONCTERNAL THERAPEUTICS INC ONCT | 2023-12-08 15:15:04 UTC | -2.776 | 8.096 | 1600000 |
ONCTERNAL THERAPEUTICS INC ONCT | 2023-12-08 14:45:04 UTC | -2.776 | 8.096 | 1600000 |
ONCTERNAL THERAPEUTICS INC ONCT | 2023-12-08 14:15:03 UTC | -2.776 | 8.096 | 1600000 |
ONCTERNAL THERAPEUTICS INC ONCT | 2023-12-08 13:45:03 UTC | 0.4158 | 4.9042 | 1600000 |
ONCTERNAL THERAPEUTICS INC ONCT | 2023-12-08 13:15:04 UTC | 0.4158 | 4.9042 | 1600000 |
ONCTERNAL THERAPEUTICS INC ONCT | 2023-12-08 12:45:05 UTC | 0.4158 | 4.9042 | 1600000 |
Holder | Issuer | Net Short Position | Position Date | Origin |
---|